1 |
CHEN Y, KNIGHT R, GALLO R L. Evolving approaches to profiling the microbiome in skin disease[J]. Front Immunol, 2023, 14: 1151527.
|
2 |
LAYTON A M, RAVENSCROFT J. Adolescent acne Vulgaris: current and emerging treatments[J]. Lancet Child Adolesc Health, 2023, 7(2): 136-144.
|
3 |
BERRY K, LIM J, ZAENGLEIN A L. Acne Vulgaris: treatment made easy for the primary care physician[J]. Pediatr Ann, 2020, 49(3): e109-e115.
|
4 |
CHUA W, POH S E, LI H. Secretory proteases of the human skin microbiome[J]. Infect Immun, 2022, 90(1): e0039721.
|
5 |
SHI J, CHENG J W, ZHANG Q, et al. Comparison of the skin microbiota of patients with acne Vulgaris and healthy controls[J]. Ann Palliat Med, 2021, 10(7): 7933-7941.
|
6 |
NUMATA S, AKAMATSU H, AKAZA N, et al. Analysis of facial skin-resident microbiota in Japanese acne patients[J]. Dermatology, 2014, 228(1): 86-92.
|
7 |
XU X X, RAN X, TANG J Q, et al. Skin microbiota in non-inflammatory and inflammatory lesions of acne Vulgaris: the underlying changes within the pilosebaceous unit[J]. Mycopathologia, 2021, 186(6): 863-869.
|
8 |
WITKOWSKI J A, PARISH L C. The assessment of acne: an evaluation of grading and lesion counting in the measurement of acne[J]. Clin Dermatol, 2004, 22(5): 394-397.
|
9 |
SPESHOCK J L, BRADY J A, EASTMAN J, et al. Impact of manure storage time and temperature on microbial composition and stable fly (Diptera: Muscidae) development[J]. AiM, 2019, 9(3): 248-265.
|
10 |
LEE Y B, BYUN E J, KIM H S. Potential role of the microbiome in acne: a comprehensive review[J]. J Clin Med, 2019, 8(7): 987.
|
11 |
BYRD A L, BELKAID Y, SEGRE J A. The human skin microbiome[J]. Nat Rev Microbiol, 2018, 16(3): 143-155.
|
12 |
KOH L F, ONG R Y, COMMON J E. Skin microbiome of atopic dermatitis[J]. Allergol Int, 2022, 71(1): 31-39.
|
13 |
SUNG K H. Microbiota in Rosacea[J]. Am J Clin Dermatol, 2020, 21(Suppl 1): 1-11.
|
14 |
SKOWRON K, BAUZA-KASZEWSKA J, KRASZEWSKA Z, et al. Human skin microbiome: impact of intrinsic and extrinsic factors on skin microbiota[J]. Microorganisms, 2021, 9(3): 543.
|
15 |
ISARD O, KNOL A C, ARIÈS M F, et al. Propionibacterium acnes activates the IGF-1/IGF-1R system in the epidermis and induces keratinocyte proliferation[J]. J Invest Dermatol, 2011, 131(1): 59-66.
|
16 |
AKAZA N, AKAMATSU H, KISHI M, et al. Effects of Propionibacterium acnes on various mRNA expression levels in normal human epidermal keratinocytes in vitro[J]. J Dermatol, 2009, 36(4): 213-223.
|
17 |
FITZ-GIBBON S, TOMIDA S, CHIU B H, et al. Propionibacterium acnes strain populations in the human skin microbiome associated with acne[J]. J Invest Dermatol, 2013, 133(9): 2152-2160.
|
18 |
DRENO B, MARTIN R, MOYAL D, et al. Skin microbiome and acne Vulgaris: Staphylococcus, a new actor in acne[J]. Exp Dermatol, 2017, 26(9): 798-803.
|
19 |
O'NEILL A M, NAKATSUJI T, HAYACHI A, et al. Identification of a human skin commensal bacterium that selectively kills cutibacteriumacnes[J]. J Invest Dermatol, 2020, 140(8): 1619-1628.e2.
|
20 |
XIA X L, LI Z H, LIU K W, et al. Staphylococcal LTA-induced miR-143 inhibits Propionibacterium acnes-mediated inflammatory response in skin[J]. J Invest Dermatol, 2016, 136(3): 621-630.
|
21 |
COTTER P D, HILL C, ROSS R P. Bacterial lantibiotics: strategies to improve therapeutic potential[J]. Curr Protein Pept Sci, 2005, 6(1): 61-75.
|
22 |
MARITO S, KESHARI S, TRAISAENG S, et al. Electricity-producing Staphylococcus epidermidis counteracts Cutibacterium acnes[J]. Sci Rep, 2021, 11(1): 12001.
|
23 |
DAGNELIE M A, CORVEC S, TIMON-DAVID E, et al. Cutibacterium acnes and Staphylococcus epidermidis: the unmissable modulators of skin inflammatory response[J]. Exp Dermatol, 2022, 31(3): 406-412.
|
24 |
LI D H, CHEN Q, LIU Y, et al. The prevalence of acne in Mainland China: a systematic review and meta-analysis[J]. BMJ Open, 2017, 7(4): e015354.
|
25 |
LI C X, YOU Z X, LIN Y X, et al. Skin microbiome differences relate to the grade of acne Vulgaris[J]. J Dermatol, 2019, 46(9): 787-790.
|
26 |
KÕLJALG U, NILSSON R H, ABARENKOV K, et al. Towards a unified paradigm for sequence-based identification of fungi[J]. Mol Ecol, 2013, 22(21): 5271-5277.
|
27 |
SU T T, LAI S C, LEE A, et al. Meta-analysis: proton pump inhibitors moderately increase the risk of small intestinal bacterial overgrowth[J]. J Gastroenterol, 2018, 53(1): 27-36.
|
28 |
PIMENTEL M, SAAD R J, LONG M D, et al. ACG clinical guideline: small intestinal bacterial overgrowth[J]. Am J Gastroenterol, 2020, 115(2): 165-178.
|
29 |
EFREMOVA I, MASLENNIKOV R, POLUEKTOVA E, et al. Epidemiology of small intestinal bacterial overgrowth[J]. World J Gastroenterol, 2023, 29(22): 3400-3421.
|